Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v5-EN
Language English English
Date Updated 2021-12-01 2021-10-01
Drug Identification Number 02414414 02414414
Brand name AURO-LAMIVUDINE/ZIDOVUDINE AURO-LAMIVUDINE/ZIDOVUDINE
Common or Proper name Auro-Lamivudine/Zidovudine Auro-Lamivudine/Zidovudine
Company Name AURO PHARMA INC AURO PHARMA INC
Ingredients ZIDOVUDINE LAMIVUDINE ZIDOVUDINE LAMIVUDINE
Strength(s) 300MG 150MG 300MG 150MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 60's 60's
ATC code J05AR J05AR
ATC description DIRECT ACTING ANTIVIRALS DIRECT ACTING ANTIVIRALS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2021-05-03 2021-05-03
Estimated end date 2021-09-30 2021-09-30
Actual end date 2021-11-30 2021-11-30
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments